Appendix B: Sources of evidence considered by the Committee

Appendix B: Sources of evidence considered by the Committee

A. The assessment report for this appraisal was prepared by the University of Sheffield, School of Health and Related Research (ScHARR)

  • Pilgrim H, Lloyd-Jones M, Rees A. Routine antenatal anti-D prophylaxis for RhD-negative women (review), November 2007.

B. The following organisations accepted the invitation to participate in this appraisal. They were invited to comment on the draft scope, assessment report and the appraisal consultation document (ACD). Organisations listed in I, II and III were also invited to make written submissions and have the opportunity to appeal against the final appraisal determination.

I) Manufacturers/sponsors:

  • Baxter BioScience (Partobulin SDF, WinRho SDF)

  • Bio Products Laboratory (D-Gam)

  • CSL Behring (Rhophylac)

II) Professional/specialist and patient/carer groups:

  • The Miscarriage Association

  • The National Childbirth Trust (NCT)

  • Association of Radical Midwives

  • NHS Blood and Transplant

  • Royal College of General Practitioners

  • Royal College of Midwives

  • Royal College of Nursing

  • Royal College of Obstetricians and Gynaecologists

  • Royal College of Paediatrics and Child Health

  • Royal College of Pathologists

  • Royal College of Physicians

III) Other organisations:

  • Bexley Care Trust PCT

  • Department of Health

  • Nottingham City PCT

  • Welsh Assembly Government

IV) Commentator organisations (without the right of appeal):

  • Department of Health, Social Services and Public Safety for Northern Ireland

  • NHS Quality Improvement Scotland

  • School of Health and Related Research, University of Sheffield

  • National Coordinating Centre for Health Technology Assessment

C. The following individuals were selected from clinical specialist and patient advocate nominations from the non-manufacturer/sponsor consultees and commentators. They participated in the Appraisal Committee discussions and provided evidence to inform the Appraisal Committee's deliberations. They gave their expert personal view on RAADP for women who are RhD negative by attending the initial Committee discussion and/or providing written evidence to the Committee. They were also invited to comment on the ACD.

  • Dr Ann Benton, Consultant Haematologist, nominated by the Royal Colleges of Pathologists and Physicians – clinical specialist

  • Dr Alan Cameron, Consultant Obstetrician, nominated by NHS Quality Improvement Scotland (QIS) – clinical specialist

  • Mrs Emma Wightman, Osteopath and NCT Antenatal Teacher Trainee, nominated by the NCT – patient expert

  • National Institute for Health and Care Excellence (NICE)